Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
about
Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis.Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.Antiinflammatory therapies for cystic fibrosis: past, present, and future.Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosisThe cystic fibrosis neutrophil: a specialized yet potentially defective cell.Bioavailability of therapeutic proteins by inhalation--worker safety aspects.The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model.Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor.Isolation and characterization of sheep alpha 1-proteinase inhibitor.Inhaled alpha 1-antitrypsin: gauging patient interest in a new treatment.
P2860
Q33760369-FD3D4148-08AF-4A6B-AA2F-8EDE5B00D34AQ34180810-E353284F-5322-400B-AD82-064011742874Q34249676-0A2F0565-982D-4C4B-9D2B-B49CA96B20E8Q36174470-100227B5-0748-4F28-B75C-F7CC488A9160Q37774788-03D00258-E6A0-4D6C-842E-6A1191F02111Q37819431-59994076-5023-4DBD-9CFC-DEB8FA967E32Q37839809-62D9BB79-3C89-4380-B440-91CF55FF2CF0Q38222723-600FE953-969F-478D-896D-E25F960D0AF1Q38322575-278140A6-53FB-41AD-9DE9-7AFA5DB2D75DQ39529387-64E9BC79-1906-4A8E-BF5B-574A227703ACQ40983959-24A855AA-A5BB-4A6F-8351-963F42D6972CQ42859611-9FE9D063-B2F0-485D-ACBA-8064FFCE5868Q46303528-554D5B58-9F78-4DC6-82A6-33CD68088EB3
P2860
Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Pulmonary deposition and clear ...... nistered to dogs and to sheep.
@ast
Pulmonary deposition and clear ...... nistered to dogs and to sheep.
@en
type
label
Pulmonary deposition and clear ...... nistered to dogs and to sheep.
@ast
Pulmonary deposition and clear ...... nistered to dogs and to sheep.
@en
prefLabel
Pulmonary deposition and clear ...... nistered to dogs and to sheep.
@ast
Pulmonary deposition and clear ...... nistered to dogs and to sheep.
@en
P2093
P2860
P356
P1476
Pulmonary deposition and clear ...... nistered to dogs and to sheep.
@en
P2093
D L Traber
L D Traber
R G Spragg
P2860
P304
P356
10.1172/JCI114278
P407
P577
1989-10-01T00:00:00Z